...
首页> 外文期刊>Bioorganic and medicinal chemistry >Sulfonamide inhibition profiles of the beta-carbonic anhydrase from the pathogenic bacterium Francisella tularensis responsible of the febrile illness tularemia
【24h】

Sulfonamide inhibition profiles of the beta-carbonic anhydrase from the pathogenic bacterium Francisella tularensis responsible of the febrile illness tularemia

机译:β-碳酸酐酶的磺酰胺抑制曲线来自致病性细菌的疾病骨髓菌,其负责发热性疾病

获取原文
获取原文并翻译 | 示例

摘要

A new (3-class carbonic anhydrase (CA, EC 4.2.1.1) has been cloned, purified and characterized in the genome of the pathogenic bacterium Francisella tularensis responsible of the febrile illness tularemia. This enzyme, FtuilCA, showed a kcal of 9.8 x 10(5) s(-1) and a kcac/KM of 8.9 x 10(7) M-1 s(-1) for the CO2 hydration, physiological reaction, being one of the most effective p-CAs known to date, with a catalytic activity only 1.68-times lower than that of the human(h) isoform hCA II. A panel of 39 simple aromatic and heterocyclic sulfonamides, as well as clinically used drugs incorporating sulfonamide/sulfamate zinc-binding groups, was used to investigate the inhibition profile of Ftu beta CA with these classes of derivatives. The enzyme generally showed a weaker affinity for these inhibitors compared to other alpha- and beta-CAs investigated earlier, with only acetazolamide and its deacetylated precursor having inhibition constant <1 mu M. Indeed, the two compounds acetazolamide AAZ and its deacetylated precursor 13 K(1)s of 655-770 nM), as well as metanilamide and methazolamide K(1)s of 2.53-2.92 I.LM), were the best Ftuf3CA inhibitors detected so far. As the physiological role of bacterial beta-CAs is poorly understood for the virulence/life cycle of these pathogens, the present study may constitute a starting point for the design of effective pathogenic bacteria CA inhibitors with potential use as antiinfectives. (C) 2017 Elsevier Ltd. All rights reserved.
机译:克隆了新的(3级碳酸酐酶(CA,EC 4.2.1.1),纯化并表征了致病性疾病术术的基因组,其负责发热性疾病患者。该酶,Ftuil​​ca,显示出9.8 x的千卡10(5)s(-1)和8.9×10(7)m-1 s(-1)的Kcac / km,用于CO 2水合,生理反应,是最有效的P-CAS之一,催化活性仅比人(H)同种型HCA II低1.68倍。使用39个简单的芳族和杂环磺酰胺,以及掺入磺酰胺/氨基磺酸锌结合基团的临床使用的药物,研究FTUβCa与这些衍生物的抑制谱。与早些时候研究的其他α-和β-β-CAS相比,该酶通常对这些抑制剂表现出较弱的亲和力,仅具有乙酰唑胺及其脱乙酰化前体具有抑制恒定的<1μm。实际上,两种化合物乙酰唑胺AA Z及其脱乙酰化前体13k(1)的655-770nm),以及迄今为止检测到的2.53-2.92 I.1m的富含甲酰胺和甲唑胺K(1)S。由于细菌β-CAS的生理作用被理解为这些病原体的毒力/生命周期,本研究可以构成具有潜在用途作为抗抗射精的有效致病菌Ca抑制剂的起点。 (c)2017 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号